Shares in Angel Biotechnology rose 80% today following the announcement that ReNeuron had commenced its Phase I clinical trial for disabled stroke patients using neural stem cells. Angel manufactures the stem cells for ReNeuron.
InvestEgate
Tuesday, 16 November 2010
Angel shares rise
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment